Martingale Asset Management »

4d Molecular Therapeutics In shares owned by Martingale Asset Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $88k 12k 7.50
2025-09-30 $91k 11k 8.69

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Cisco Systems (CSCO)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Visa (V)
Exxon Mobil Corporation (XOM)
Wal-Mart Stores (WMT)
NVIDIA Corporation (NVDA)
MasterCard Incorporated (MA)

View all positions for Martingale Asset Management

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In